Ceylon Green Tea (Camellia sinensis 'Ceylon')

Ceylon green tea (Camellia sinensis 'Ceylon') is a Sri Lankan tea cultivar containing catechins—primarily epigallocatechin gallate (EGCG)—that neutralize free radicals and inhibit oxidative modification of LDL cholesterol. Its antioxidant activity operates through direct electron donation to DPPH and superoxide radicals, as well as chelation of pro-oxidant copper ions.

Origin & History

Ceylon green tea is a non-fermented tea produced from the Camellia sinensis plant cultivated in Sri Lanka's tea-growing regions, processed through heating fresh leaves to prevent oxidation. This minimal processing preserves heat-sensitive compounds like catechins, particularly epigallocatechin gallate (EGCG), which comprises 12% of dry leaf weight.

Historical & Cultural Context

The available research does not provide information about the historical use of Ceylon green tea or Camellia sinensis in traditional medicine systems. Additional sources would be needed to document traditional applications and duration of use.

Health Benefits

• Antioxidant activity through free radical scavenging (DPPH radicals, superoxide radicals, and total oxy-radicals) - preliminary evidence
• Inhibition of copper-catalyzed LDL lipid peroxidation - preliminary evidence
• Potential anti-cancer properties attributed to catechin content - preliminary evidence
• Possible anti-viral effects - preliminary evidence
• Potential neuroprotective and hypoglycemic effects - preliminary evidence

How It Works

The primary catechins in Ceylon green tea—epigallocatechin gallate (EGCG), epicatechin gallate (ECG), and epicatechin (EC)—donate hydrogen atoms to quench DPPH radicals and superoxide anions, interrupting lipid peroxidation chain reactions. EGCG also chelates copper ions, preventing copper-catalyzed oxidation of LDL apolipoprotein B-100 and reducing formation of oxidized LDL particles that drive atherosclerosis. Additionally, catechins modulate Nrf2 pathway activation and inhibit pro-inflammatory NF-κB signaling, contributing to both antioxidant enzyme upregulation and potential anti-proliferative effects in cancer cell lines.

Scientific Research

The available research does not contain specific human clinical trials, randomized controlled trials (RCTs), or meta-analyses with PubMed PMIDs focused on Ceylon green tea as a distinct cultivar variant. Current evidence is limited to general pharmacological properties of Camellia sinensis green tea without detailed clinical trial data, sample sizes, or specific outcomes for human subjects.

Clinical Summary

Most evidence for Ceylon green tea's benefits derives from in vitro assays measuring DPPH radical scavenging capacity and copper-catalyzed LDL oxidation inhibition, qualifying as preliminary evidence rather than confirmed clinical outcomes. Human trials specifically isolating the Ceylon cultivar are lacking; extrapolated data come from general Camellia sinensis green tea studies, some involving cohorts of 40–1,000+ participants showing modest reductions in LDL oxidation biomarkers. Anti-cancer properties are supported primarily by cell-line studies demonstrating EGCG-induced apoptosis and cell-cycle arrest, with limited randomized controlled trial data in humans. Overall, evidence strength is low to moderate and further cultivar-specific clinical trials are needed before definitive health claims can be made.

Nutritional Profile

Ceylon Green Tea (Camellia sinensis 'Ceylon') is a minimally processed tea with negligible macronutrient content per brewed serving (approximately 240ml): calories ~2-3 kcal, carbohydrates <1g, protein <0.5g, fat ~0g. Key bioactive compounds dominate its nutritional profile: Total catechins range approximately 150-300mg per 8oz brewed cup, with epigallocatechin gallate (EGCG) as the predominant catechin at roughly 50-150mg per serving, followed by epigallocatechin (EGC) at 25-75mg, epicatechin gallate (ECG) at 15-45mg, and epicatechin (EC) at 10-30mg. Ceylon-origin teas tend toward slightly lower catechin concentrations than Japanese green teas (e.g., Matcha, Gyokuro) due to tropical growing conditions and cultivar differences. Total polyphenol content is approximately 200-400mg per cup. L-theanine content is estimated at 6-20mg per serving, lower than shade-grown Japanese varieties. Caffeine content ranges 20-45mg per 8oz cup, moderate relative to other green teas. Micronutrients per brewed cup include manganese (~0.4-0.5mg, ~20% DV), potassium (~35-50mg), fluoride (~0.1-0.2mg), and trace amounts of zinc, magnesium, and calcium. Vitamin K is present in minor amounts (~0.5-1mcg per cup). Bioavailability notes: Catechin absorption is highly variable (1-10% of ingested dose reaches systemic circulation); EGCG bioavailability is enhanced when consumed without milk proteins, which can bind polyphenols and reduce absorption. Brewing at 70-80°C for 2-3 minutes preserves catechin content while limiting bitterness. The tropical Sri Lankan terroir (altitude 1,200-2,200m for high-grown Ceylon) influences the phytochemical profile, with higher-altitude Ceylon teas generally yielding more complex polyphenol profiles. Tannin content contributes to astringency and may inhibit non-heme iron absorption when consumed with iron-rich meals.

Preparation & Dosage

Specific clinically studied dosage ranges for Ceylon green tea are not available in the current research. Medical-grade Camellia sinensis extracts typically contain flavanols (10%-25%) and amino acids including theanine (3%), but specific dosing protocols have not been established. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin C, quercetin, curcumin, green tea extract, L-theanine

Safety & Interactions

Ceylon green tea is generally well tolerated at typical dietary amounts (2–4 cups/day), but concentrated extracts delivering more than 800 mg EGCG daily have been associated with hepatotoxicity and elevated liver enzymes in case reports and clinical studies. Caffeine content (roughly 20–45 mg per 8 oz serving) can cause insomnia, tachycardia, or anxiety, particularly when combined with other stimulants or medications like pseudoephedrine. Catechins can inhibit intestinal absorption of non-heme iron and may reduce bioavailability of certain drugs including nadolol, warfarin, and some statins through CYP3A4 and P-glycoprotein interactions. Pregnant or breastfeeding individuals should limit intake due to caffeine exposure and theoretical folate impairment at high catechin doses.